![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print October 1, 2006
Dept. of Pharmacology, School of Medicine, Univ. of Pennsylvania, Philadelphia, PA 19104
Corresponding Author: field{at}pharm.med.upenn.edu
The Akt/PKB isoforms have different roles in animals, with Akt2 primarily regulating metabolic signaling and Akt1 regulating growth and survival. Here we show distinct roles for Akt1 and Akt2 in MEF (Mouse Embryo Fibroblast) cell migration and regulation of the cytoskeleton. Akt1 deficient cells responded poorly to PDGF while Akt2 deficient cells had a dramatically enhanced response, resulting in a substantial increase in dorsal ruffling. Swapping domains between Akt1 and Akt2 demonstrated that the N-terminal region containing the pleckstrin homology (PH) domain and a linker region distinguishes the two isoforms, while the catalytic domains are interchangeable. Akt2 knockout cells also migrated faster than wild type cells, especially through extracellular matrix (ECM), while Akt1 knockout cells migrated more slowly than wild type cells. Consistently, Akt2 knockout cells had elevated Pak1 and Rac activities, suggesting that Akt2 inhibits Rac and Pak1. Both Akt2 and Akt1 associated in complexes with Pak1, but only Akt2 inhibited Pak1 in kinase assays suggesting an underlying molecular basis for the different cellular phenotypes. Together these data provide evidence for an unexpected functional link between Akt2 and Pak1 that opposes the actions of Akt1 on cell migration.
J. Biol. Chem, 10.1074/jbc.M600788200
Submitted on January 25, 2006
Accepted on October 1, 2006
Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. D. Basson An Intracellular Signal Pathway That Regulates Cancer Cell Adhesion in Response to Extracellular Forces Cancer Res., January 1, 2008; 68(1): 2 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Martin, B. L. Merenick, M. Ding, K. M. Fetalvero, E. M. Rzucidlo, C. D. Kozul, D. J. Brown, H. Y. Chiu, M. Shyu, B. L. Drapeau, et al. Rapamycin Promotes Vascular Smooth Muscle Cell Differentiation through Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase/Akt2 Feedback Signaling J. Biol. Chem., December 7, 2007; 282(49): 36112 - 36120. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sheehan, Y. Ke, and R. J. Solaro p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D.-A. Tran, T. P. Marmo, A. A. Salam, S. Che, E. Finkelstein, R. Kabarriti, H. S. Xenias, R. Mazitschek, C. Hubbert, Y. Kawaguchi, et al. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions J. Cell Sci., April 15, 2007; 120(8): 1469 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fang, D. Hawke, Y. Zheng, Y. Xia, J. Meisenhelder, H. Nika, G. B. Mills, R. Kobayashi, T. Hunter, and Z. Lu Phosphorylation of beta-Catenin by AKT Promotes beta-Catenin Transcriptional Activity J. Biol. Chem., April 13, 2007; 282(15): 11221 - 11229. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hayes, P. E. Carrigan, and L. J. Miller Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas Cancer Res., March 1, 2007; 67(5): 2072 - 2080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |